MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about clarification

28 Feb 2022 Evaluate
Jagsonpal Pharmaceuticals has informed that do not have any information or announcement (including pending announcement) which in opinion may have a bearing on the price behaviour of the Scrip. Therefore, the movement in the Share price of the Company is purely due to Market Conditions and absolutely market driven and management of the Company is in no way connected with any such movement of price.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1751.80
Dr. Reddys Labs. 1235.90
Cipla 1328.10
Lupin 1960.00
Zydus Lifesciences 1123.40
View more..